BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2012
View Archived Issues
Kyowa Hakko Kirin withdraws Japanese submission for Nesp
Read More
Tyrosine-protein kinase SYK inhibitors may counter retinoblastoma
Read More
Roche prepares new HCV NS5B inhibitors
Read More
Researchers at Gilead Sciences prepare novel sodium channel blockers
Read More
Gilead Sciences discloses new agents for HIV infection
Read More
Novel DNA-dependent protein kinase inhibitors claimed by Merck KGaA
Read More
Korean scientists prepare novel compounds with muscle relaxant activity
Read More
New treatment for rosacea designed by Galderma Pharma
Read More
Marker of multiple sclerosis duration identified in cerebrospinal fluid
Read More
Study identifies markers of treatment response in ovarian cancer
Read More
NanoViricides submits pre-IND briefing document to FDA for FluCide
Read More
Ampion demonstrates improvement in pain relief in osteoarthritis
Read More
AcelRx Pharmaceuticals gives update on ARX-01
Read More
FDA accepts NPS Pharmaceuticals' NDA for teduglutide
Read More
Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor
Read More
TGen and University of Arizona receive funding for cancer research
Read More
Astellas and UCB sign Japanese development and commercialization agreement for Cimzia
Read More
Janssen seeks approval for Velcade subcutaneous injection in Japan
Read More
Juventas Therapeutics reports 1-year data for JVS-100
Read More
Pfizer recaps progress of 2011
Read More
Starpharma's dendrimer-docetaxel formulation shows superiority to docetaxel in breast cancer model
Read More
FDA approves ivacaftor for rare form of cystic fibrosis
Read More
TiGenix's study of Cx-611 in rheumatoid arthritis cleared to open final cohort
Read More
Mesoblast receives FDA clearance to conduct stem cell therapy study in diabetes
Read More
NIH joins phase II tuberculosis vaccine trial
Read More
